Ultrasonographic Response to Polarized Light Therapy in the Treatment of Atopic Dermatitis

Last updated: August 20, 2023
Sponsor: Ahram Canadian University
Overall Status: Terminated

Phase

N/A

Condition

Dermatitis, Atopic

Allergy

Rash

Treatment

Topical corticosteroid ointment

polarized light

Clinical Study ID

NCT04955951
AhramCUE
  • Ages 20-30
  • Male

Study Summary

Non-atopic dermatitis (NAD) or eczema is a common inflammatory condition; potentially debilitating that can compromise quality of life. It is usually seen in childhood, but can onset within or persist into adulthood.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • The patients' ages will ranged from 20 to 30 years.
  • The subjects will be males.
  • The duration of disease less than 1 year.

Exclusion

Exclusion Criteria:

  • patients who had skin malignancy in the area to be treated.
  • The patients who had history of diabetes, circulatory or sensory disorders.
  • Patients with acute infection in the area treated.

Study Design

Total Participants: 40
Treatment Group(s): 2
Primary Treatment: Topical corticosteroid ointment
Phase:
Study Start date:
July 01, 2021
Estimated Completion Date:
January 15, 2022

Study Description

Polarized ultraviolet-free polychromatic light is used as therapeutic option for the treatment of wound healing and dermatological conditions.

40 male patients who had atopic dermatitis in the chronic stage, they were complaining from itching, inflammation and skin thickness in the arm, wrist, hand and leg will participate in this study.

Connect with a study center

  • Ahram Canadian University

    Giza,
    Egypt

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.